The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
Abstract The aim of this study was to investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and pancreatic steatosis (PS) in patients with biopsy-proven NAFLD. 228 patients with biopsy-proven NAFLD patients who admitted to the Faculty of Medicine of Demiroglu Bilim University...
Guardado en:
Autores principales: | Bedriye Koyuncu Sokmen, Tolga Sahin, Alihan Oral, Erdem Kocak, Nagihan Inan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f6b2b6044184c8894ca4fb7452c890d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
por: Dieter Broering, et al.
Publicado: (2021) -
Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Fatih Türker, et al.
Publicado: (2021) -
Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Wonsuk Choi, et al.
Publicado: (2018) -
Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906
por: Kazuki Tajima, et al.
Publicado: (2017) -
Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Wonsuk Choi, et al.
Publicado: (2019)